Ileana Fumero
Psychiatry · San Juan, PRNPI 1083828578
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $103,035 of the $127,690 with a category attached, or 80.7%. 11 manufacturers reported payments, led by Johnson & Johnson at 54.3% of the total. Among psychiatry clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $585.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$69K
- AbbVie$31K
- E.r. Squibb & Sons, L.L.C.$16K
- Teva Pharmaceuticals USA, Inc.$10K
- Janssen Scientific Affairs, LLC$200
- Sunovion Pharmaceuticals Inc.$169
- plus $293 from 5 others
Across 303 payments — averaging $3425.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurocrine Biosciences, Inc.$317K
- Eli Lilly Export S.A. Puerto Rico Branch$266K
- Alkermes, Inc.$149K
- AbbVie$147K
- Supernus Pharmaceuticals, Inc.$105K
- E.r. Squibb & Sons, L.L.C.$19K
- plus $34K from 3 others
What the payments were for
- Consulting fees$13,44911%
- Speaking & faculty fees$103,03581%
- Travel & lodging$5,3554%
- Food & beverage$5,8535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 87 | $69,363 |
| AbbVie | 58 | $31,216 |
| E.r. Squibb & Sons, L.L.C. | 44 | $16,024 |
| Teva Pharmaceuticals USA, Inc. | 10 | $10,425 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Sunovion Pharmaceuticals Inc. | 9 | $169 |
| Otsuka America Pharmaceutical, Inc. | 1 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| Biogen | 1 | $27 |
| Alkermes, Inc. | 1 | $26 |
| Shire North American Group Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$48,712
- VRAYLAR$30,588
- INVEGA TRINZA$25,014
- INVEGA$16,443
- COBENFY$14,062
- AUSTEDO$10,079
- SPRAVATO$1,850
- AJOVY$130
- UZEDY$119
- REXULTI$118
How this compares
$127,690 in reported general payments places this provider in the 95th percentile of 312 psychiatry providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $92,231 |
| MyrbetriqMirabegron | 12 | $5,547 |
| PristiqDesvenlafaxine Succinate | 11 | $4,874 |
| Bupropion XlBupropion Hcl | 74 | $2,383 |
| Clorazepate Dipotassium | 38 | $2,306 |
| Trazodone Hcl | 130 | $2,252 |
| Clonazepam | 238 | $2,148 |
| Donepezil Hcl | 130 | $2,046 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 46 | $1,594 |
| Paroxetine CrParoxetine Hcl | 18 | $1,495 |
| Estazolam | 25 | $1,436 |
| Memantine Hcl ErMemantine Hcl | 31 | $1,432 |
| Sertraline Hcl | 157 | $1,382 |
| Rivastigmine | 13 | $1,297 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $1,269 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $31,216 | $94319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 312 psychiatry providers in Puerto Rico.
Other psychiatry in San Juan
- Ivonne VicenteSan Juan$49K
- Jose Alonso AlonsoSan Juan$46K
- William LugoSan Juan$12K
- Michel WoodburySan Juan$6K
- Annabelle Rodriguez LlaugerSan Juan$3K
- Analid DiazSan Juan$3K
- Lillian Arroyo RiveraSan Juan$2K
- Alisha Subervi VazquezSan Juan$2K
- Roberto Cardona-QuinonesSan Juan$2K
- Fernando Martinez SchmidtSan Juan$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.